Whalesbook
Rubicon Research Ltd. is strategically focusing on drug-device combinations, with nasal spray emerging as a key growth area. CEO Parag Sancheti highlighted the scientific challenges and market opportunity, especially alternatives to injectables in the US. This move leverages the company's expertise in formulation science and regulatory pathways to tap complex, high-barrier segments for global expansion.